Project Grant R21EY036683

Award Date 9/1/24
Completion Date 8/31/26
Dollars Obligated $246K
Federal Grant Program
93.867
Assistance Type
Project Grant
Place of Performance
California, USA
Similar Awards
The National Eye Institute (NEI), through its Vision Research federal grant program (CFDA 93.867), awarded a $247,800 Project Grant to Oregon Health & Science University (OHSU) to develop novel tools to help diagnose and classify uveitis, a common cause of blindness in the United States. The project aims to (1) develop ultrahigh-resolution optical coherence tomography (OCT) for imaging the anterior and vitreous media of the eye, and (2) quantify and classify inflammation in the aqueous and...
The National Eye Institute (NEI), part of the National Institutes of Health, awarded a $252,573 Project Grant (CFDA 93.867 - Vision Research) to the Regents of the University of California, San Francisco (UCSF) for the "UCSF Program in Resident Opportunities for Mentored Ophthalmic Training in Experimentation (PROMOTE)" project. The program aims to recruit, train, mentor, and launch diverse resident-investigators with both clinical expertise and scientific, methodological, and...
The National Eye Institute (NEI) awarded a $231,000 Project Grant under the Vision Research federal grant program (CFDA 93.867) to the University of Tennessee Health Science Center (UTHSC) to develop a generalizable deep learning platform for unifying the quantification and assessment of experimental autoimmune uveitis (EAU). The overarching goals of this 2-year project are to: 1) Generate high-quality, multi-modal datasets of fundus, optical coherence tomography, histological, and...
The National Eye Institute (NEI) awarded a $1,083,078 Project Grant under the Vision Research federal grant program (CFDA 93.867) to the University of California, Irvine (UCI) to conduct research on the role of monocytes and neutrophils in fungal keratitis. The project aims to examine neutrophil activation and the effect of monocyte depletion on neutrophil function in infected corneas, investigate the role of ICAM-1+ neutrophils and the HV1 proton channel in fungal keratitis, and explore the...
This Project Grant award from the National Eye Institute (NEI), under the federal Vision Research program (CFDA 93.867), aims to develop a refillable micromachined lens capsule-based drug delivery device for extended intraocular delivery of biologics and immune-modulating peptides to treat non-infectious uveitis. The $257,785 award to The Leland Stanford Junior University (Stanford University) will support research to characterize and control the release of adalimumab and a novel...
This federal Project Grant award from the National Eye Institute (CFDA 93.867 Vision Research) provides $246,000 to The Regents of the University of California, San Francisco to conduct research on serum components that support corneal health. The goal is to define the combinations of serum factors, such as growth factors, signaling lipids, and vitamins, that can restore healthy corneal function and treat diverse ocular surface disorders. The research aims to improve the clinical use of...
This Project Grant award from the National Eye Institute (NEI), under the Vision Research program (CFDA 93.867), aims to develop a rapid, culture-independent diagnostic approach for detecting pathogens and antimicrobial resistance in sight-threatening ocular infections. The $425,000 award, effective August 1, 2024 through July 31, 2029, will support the Massachusetts Eye and Ear Infirmary in creating a metagenomic sequencing-based platform that uses portable nanopore sequencers to provide...
The National Eye Institute (NEI) awarded a $488,639 Project Grant under the Vision Research federal grant program (CFDA 93.867) to the University of Pittsburgh to identify the mechanisms underlying the enhanced virulence of an extensively drug-resistant (XDR) strain of Pseudomonas aeruginosa that has caused a concerning outbreak of keratitis infections. The funding will support research to systematically test the unique virulence factors of this outbreak strain and develop more effective...
The National Eye Institute (NEI), under the federal Vision Research grant program (CFDA 93.867), has awarded a $1,448,874 Cooperative Agreement to The Regents of the University of California, San Francisco (UCSF) to extend the Village-Integrated Eye Worker Trial II (VIEW II) study in Nepal. The goal of this 5-year project is to determine if a community-based eye disease screening intervention, which utilizes optical coherence tomography, intraocular pressure assessment, and fundus photography,...
This federal Project Grant award from the National Eye Institute (NEI) under the Vision Research program (CFDA 93.867) provides $719,012 to the University of California, Davis to optimize the delivery of adeno-associated virus (AAV) gene therapies into the suprachoroidal space of non-human primates for the treatment of retinal diseases. The key objectives are to: 1) evaluate techniques to enhance the posterior biodistribution of suprachoroidal AAV delivery, 2) screen engineered AAV capsids to...

This federal Project Grant award from the National Eye Institute (NEI), under the Vision Research program (CFDA 93.867), provides $246,000 to The Regents of the University of California, San Francisco (UCSF) to leverage programmable phage display peptidomes and high-throughput sequencing to identify autoantigens and antibodies important for uveitis, an ocular inflammatory disease. The two-year project aims to use comprehensive human and viral peptidome phage libraries to bio-pan for autoantigens in intraocular fluid and tear specimens of patients with idiopathic anterior uveitis, as well as viral antibodies in intraocular fluid and plasma of patients with presumed viral-associated anterior uveitis. The anticipated outcomes include the development of new diagnostics to improve patient care and clinical outcomes for this challenging condition.

Generated 7/1/25, 2:27 AM